BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9835453)

  • 1. Nodular histogenetic type -- the most significant factor for thick melanoma: implications for prevention.
    Bergenmar M; Ringborg U; Månsson Brahme E; Brandberg Y
    Melanoma Res; 1998 Oct; 8(5):403-11. PubMed ID: 9835453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thick malignant melanoma is a long-term problem.
    Asquith PR; Barnett JM; Lockett BK
    N Z Med J; 1999 Aug; 112(1094):313-6. PubMed ID: 10493441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nodular histogenetic type--the most significant factor for thick melanoma: implications for prevention.
    Heenan PJ; Yu LL; English DR
    Melanoma Res; 1999 Jun; 9(3):303-4. PubMed ID: 10465587
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group.
    Cox NH; Aitchison TC; Sirel JM; MacKie RM
    Br J Cancer; 1996 Apr; 73(7):940-4. PubMed ID: 8611411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical correlates of Breslow thickness of malignant melanoma.
    Osborne JE; Hutchinson PE
    Br J Dermatol; 2001 Mar; 144(3):476-83. PubMed ID: 11260002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of a polypoid configuration in malignant melanoma.
    McGovern VJ; Shaw HM; Milton GW
    Histopathology; 1983 Sep; 7(5):663-72. PubMed ID: 6629342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors related to the presentation of thin and thick nodular melanoma from a population-based cancer registry in Queensland Australia.
    Geller AC; Elwood M; Swetter SM; Brooks DR; Aitken J; Youl PH; Demierre MF; Baade PD
    Cancer; 2009 Mar; 115(6):1318-27. PubMed ID: 19189368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous malignant melanoma in southern Sweden 1965, 1975, and 1985. Prognostic factors and histologic correlations.
    Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
    Cancer; 1997 Jan; 79(2):275-83. PubMed ID: 9010101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Survival analysis in patients with cutaneous malignant melanoma].
    Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
    Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of the histological features of malignant melanoma.
    McGovern VJ; Shaw HM; Milton GW; Farago GA
    Histopathology; 1979 Sep; 3(5):385-93. PubMed ID: 488922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes from mid-1980s to late 1990s among clinical and demographic correlates of melanoma thickness.
    Crocetti E; Carli P
    Eur J Dermatol; 2003; 13(1):72-5. PubMed ID: 12609787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thick melanoma: the challenge persists.
    Murray CS; Stockton DL; Doherty VR
    Br J Dermatol; 2005 Jan; 152(1):104-9. PubMed ID: 15656809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma in people aged 65 and over in Scotland, 1979-89.
    McHenry PM; Hole DJ; MacKie RM
    BMJ; 1992 Mar; 304(6829):746-9. PubMed ID: 1571680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant melanoma in the elderly.
    Cohen HJ; Cox E; Manton K; Woodbury M
    J Clin Oncol; 1987 Jan; 5(1):100-6. PubMed ID: 3806154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nature of melanoma. A critical review.
    McGovern VJ
    J Cutan Pathol; 1982 Apr; 9(2):61-81. PubMed ID: 7047599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
    Skender-Kalnenas TM; English DR; Heenan PJ
    J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors involved in presentation of older people with thick melanoma.
    Hanrahan PF; Hersey P; D'Este CA
    Med J Aust; 1998 Oct; 169(8):410-4. PubMed ID: 9830387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of thick melanomas in the United States: beware of the nodular subtype.
    Demierre MF; Chung C; Miller DR; Geller AC
    Arch Dermatol; 2005 Jun; 141(6):745-50. PubMed ID: 15967921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in invasive cutaneous malignant melanoma: a population-based study and review.
    Måsbäck A; Olsson H; Westerdahl J; Ingvar C; Jonsson N
    Melanoma Res; 2001 Oct; 11(5):435-45. PubMed ID: 11595879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [From dysplastic nevus to malignant melanoma--a study of 4 anatomoclinical cases of dysplastic nevus syndrome].
    Huynh Do P; Joris F
    Praxis (Bern 1994); 1997 Nov; 86(47):1854-9. PubMed ID: 9480503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.